You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Methocarbamol - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic drug sources for methocarbamol and what is the scope of freedom to operate?

Methocarbamol is the generic ingredient in five branded drugs marketed by Dr Reddys, Marsam Pharms Llc, Am Regent, Baxter Hlthcare Corp, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Monterey Pharms Llc, Navinta Llc, Norvium Bioscience, Sagent Pharms Inc, Slate Run Pharma, Somerset Theraps Llc, Hikma, Ferndale Labs, Forest Labs, Able, Allied, Am Therap, Ani Pharms, Ascot, Aurobindo Pharma Ltd, Beximco Pharms Usa, Chartwell Molecular, Clonmel Hlthcare, Fosun Pharma, Granules, Hangzhou Binjiang, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Hlthcare, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Mikart, Mylan, Nylos, Oxford Pharms, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Watson Labs, and Endo Operations, and is included in seventy-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for methocarbamol. Sixty-two suppliers are listed for this compound.

Summary for methocarbamol

US Patents:	0
Tradenames:	5
Applicants:	53
NDAs:	74
Drug Master File Entries:	27
Finished Product Suppliers / Packagers:	62
Raw Ingredient (Bulk) Api Vendors:	105
Clinical Trials:	10
Patent Applications:	5,418
Drug Prices:	Drug price trends for methocarbamol
Drug Sales Revenues:	Drug sales revenues for methocarbamol
What excipients (inactive ingredients) are in methocarbamol?	methocarbamol excipients list
DailyMed Link:	methocarbamol at DailyMed

Drug Prices for methocarbamol

See drug prices for methocarbamol

Drug Sales Revenue Trends for methocarbamol

See drug sales revenues for methocarbamol

Recent Clinical Trials for methocarbamol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Allucent	Phase 3
Arthritis Innovation Corporation	Phase 3
Prisma Health-Upstate	Phase 4

See all methocarbamol clinical trials

Pharmacology for methocarbamol

Drug Class	Muscle Relaxant
Physiological Effect	Centrally-mediated Muscle Relaxation

Medical Subject Heading (MeSH) Categories for methocarbamol

Muscle Relaxants, Central

Anatomical Therapeutic Chemical (ATC) Classes for methocarbamol

M03BA	Carbamic acid esters
M03B	MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
M03	MUSCLE RELAXANTS
M	Musculo-skeletal system

US Patents and Regulatory Information for methocarbamol

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Norvium Bioscience	METHOCARBAMOL	methocarbamol	SOLUTION;IM-IV	204404-001	Dec 5, 2014		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Solvay	METHOCARBAMOL	methocarbamol	TABLET;ORAL	084449-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Heather	METHOCARBAMOL	methocarbamol	TABLET;ORAL	084924-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Heather	METHOCARBAMOL	methocarbamol	TABLET;ORAL	084675-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Ivax Sub Teva Pharms	METHOCARBAMOL	methocarbamol	TABLET;ORAL	084649-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Navinta Llc	METHOCARBAMOL	methocarbamol	SOLUTION;IM-IV	206071-001	Nov 24, 2017	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.